logo-loader
CSE:AGN OTCQB:BTHCF

Algernon Pharmaceuticals Inc.

Receive alerts
Market:
CSE
Market Cap:
$37.97 m
Price
0.35 CAD
Change
-2.82%
52 weeks high
0.58
52 weeks low
0.04

In brief

Algernon Pharmaceuticals is a clinical stage pharmaceutical development company focused on the areas of non–alcoholic steatohepatitis (NASH), chronic kidney disease (CKD) and inflammatory bowel disease (IBD). Algernon’s key compounds were identified using a drug repurposing strategy.

Deep dive We explore the investor case for growth companies

Snapshot

The firm says repurposed compounds have a much lower risk of failing in human trials on safety issues